Stifel Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $33
Stifel analyst Jonathan Block initiates coverage on Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $33.
Cowen & Co. Initiates Coverage On Beauty Health with Outperform Rating, Announces Price Target of $32
Cowen & Co. analyst Oliver Chen initiates coverage on Beauty Health (NASDAQ:SKIN) with a Outperform rating and announces Price Target of $32.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.
78 Biggest Movers From Friday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
‘Fast Money Halftime Report’ Picks For August 13
On CNBC's "Fast Money Halftime Report," Kevin O'Leary said he loves Beauty Health Co (NASDAQ: SKIN). It has a fantastic team and management and it is growing over 40% a year.
Understanding Beauty Health’s Unusual Options Activity
Shares of Beauty Health (NASDAQ:SKIN) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $22.18.